Partners
Partners

Partner 7 - University Hospital Düsseldorf


Nikolas Stoecklein Heinrich Heine Universität Düsseldo

Prof. Dr. Nikolas Stoecklein

 

Principal Investigator

 

Phone: +49 2118116399

undefinedE-Mail

 

University Hospital  Düsseldorf

 

Moorenstr. 5

40225 Düsseldorf

Germany

undefinedWebsite

CANCER-ID Team Düsseldorf

Dr. rer. nat. Rui Neves

Post-Doc at CHA / UDUS

 

Supports coordination of CANCER-ID at UDUS; Involved in CTC detection, isolation, and genomic characterization of WP0, WP1, and WP2

 

Phone: +49 211 8104502

undefinedE-Mail

 

 

Dr. rer. nat Birte Möhlendick

Post-Doc at CHA / UDUS

 

Supports genomic characterization of CTCs in WP0, WP1, and WP2

 

Phone: +49 211 8104502

undefinedE-Mail

Christiane Driemel

Staff Biologist at CHA / UDUS

 

Supports coordination of CANCER-ID at UDUS; Involved in CTC detection, isolation, and genomic characterization of WP0, WP1, and WP2

 

Phone: +49 211 8104580

undefinedE-Mail

 

 

Dr. med Johannes Fischer

Associate Director of ITZ / UDUS

 

Performs DLA at UDUS in WP1 and provides expertise for CTC-flow sorting / isolation in WP1

 

Phone: +49 211 8116457

undefinedE-Mail

Dr. rer. nat. Dieter Niederacher

Head of Molecular Genetics Laboratory at GYN / UDUS

 

Provides expertise in analysing DLA samples for WP1, CTC detection, isolation and molecular characterization for WP0, WP1 and WP2.

 

Phone: +49 211 385428120

undefinedE-Mail

 

 

Prof. Dr. rer. nat. Hans Neubauer

Group leader at GYN / UDUS

 

CTC detection, isolation and molecular characterization for WP0, WP1 and WP2.

 

Phone: +49 211 385428118

undefinedE-Mail

Prof. Dr. med. Tanja Fehm

Professor, Medical Faculty of UDUS

Director of Obstetrics and Gynecology (GYN) / UDUS

 

Recruites patients for WP2 and provides expertise in CTC detection, isolation and molecular analysis to WP0, WP1 and WP2

 

Phone: +49 211 8108087

undefinedE-Mail

 

 

Prof. Dr. med. Norbert Gattermann

Associate Professor of Medicine

 

Managing Director of the University Cancer Center / UDUS

Patient recruitment in WP01

 

Phone: +>49 211 8116 500

undefinedE-Mail

Priv.-Doz. Dr. med. Thomas Wündisch

Senior consultant physiscian

University Cancer Center / UDUS

 

Patient recruitment in WP01

 

Phone: +49 211 8116338

undefinedE-Mail

Institute presentation

The University Hospital of the Heinrich Heine University Düsseldorf (UDUS) is located within the most densely populated area in Germany. With 47.000 admissions and 160.000 outpatients per year, UDUS is one of the most important clinical centers of the region. The oncology focus of UDUS is reflected by election of its University Cancer Center as one of twelve German Interdisciplinary Oncology Centers of Excellence by the "Deutsche Krebshilfe" (German Cancer Aid) in 2013.


At UDUS an interdisciplinary team of researchers and clinicians focus their research on circulating tumor cells and are organized within the “Disseminated Cancer Cell Network” (DCC Net) Düsseldorf. Members of the DCCNet (Lead by Nikolas Stoecklein and Tanja Fehm) have pioneered Diagnostic Leukapheresis (DLA), genomic high-resolution profiling of single cells, and are involved in clinical trials testing the prognostic and predictive value of CTCs. The goal of the DCCNet is to better understand systemic disease in cancer and to improve individualized therapy in cancer patients.


Competence of the DCCNet at UDUS relevant for CANCER-ID:

 

  •    Diagnostic Leukapheresis (DLA)
  •    CTC detection in DLA products (CellSearchTM)
  •    CTC detection in blood using different platforms (CellSearchTM, Gilupi,  VyCAP, IsofluxTM)
  •    Isolation of single CTCs (Flow sorting, manual Micromanipulation, automated micromanipulation by ALS CellCelectorTM)
  •    Molecular single cell characterization (WGA, aCGH, NGS, qPCR, IF-staining)

 

 

 

 

CANCER-ID Consortium

CANCER-ID consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

Hands-on courses provided by our member TATAA Read more

Social Media

LinkedIn Cancer-ID